BC
Burney Company Portfolio holdings
AUM
$2.95B
This Quarter Return
+4.08%
1 Year Return
+27.49%
3 Year Return
+99.49%
5 Year Return
+205.38%
10 Year Return
+393.02%
AUM
$1.65B
AUM Growth
+$1.65B
(+2.2%)
Cap. Flow
-$17.7M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
16.84%
Holding
467
New
22
Increased
138
Reduced
250
Closed
24
Top Buys
| 1 |
NorthWestern Energy
NWE
|
$5.81M |
| 2 |
Chevron
CVX
|
$5.29M |
| 3 |
Capital One
COF
|
$5.29M |
| 4 |
Quanta Services
PWR
|
$5.27M |
| 5 |
McKesson
MCK
|
$4.8M |
Top Sells
| 1 |
Biogen
BIIB
|
$7.26M |
| 2 |
Amdocs
DOX
|
$6.62M |
| 3 |
AutoZone
AZO
|
$5.01M |
| 4 |
CVS Health
CVS
|
$4.94M |
| 5 |
HP
HPQ
|
$4.25M |
Sector Composition
| 1 | Technology | 18.42% |
| 2 | Industrials | 16.4% |
| 3 | Financials | 14.77% |
| 4 | Consumer Discretionary | 11.84% |
| 5 | Healthcare | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Las Vegas Sands
LVS
$39.6B
| $320K | 0.02% | 5,420 -675 | -11% | -$39.9K |
|
377
Mondelez International
MDLZ
$79.5B
| $320K | 0.02% | 5,942 +219 | +4% | +$11.8K |
|
378
Berkshire Hathaway Class A
BRK.A
$1.09T
| $318K | 0.02% | 1 | – | – |
|
379
Quest Diagnostics
DGX
$20.3B
| $317K | 0.02% | 3,112 -36 | -1% | -$3.67K |
|
380
World Acceptance Corp
WRLD
$934M
| $317K | 0.02% | 1,932 -60 | -3% | -$9.85K |
|
381
EPR Properties
EPR
$4.13B
| $316K | 0.02% | 4,240 | – | – |
|
382
Wyndham Hotels & Resorts
WH
$6.61B
| $311K | 0.02% | 5,580 -2,125 | -28% | -$118K |
|
383
Ameren
AEE
$27B
| $308K | 0.02% | 4,095 +205 | +5% | +$15.4K |
|
384
Seagate
STX
$35.6B
| $299K | 0.02% | 6,348 -255 | -4% | -$12K |
|
385
Energy Transfer Partners
ET
$60.8B
| $298K | 0.02% | 21,161 +243 | +1% | +$3.42K |
|
386
TE Connectivity
TEL
$61B
| $290K | 0.02% | 3,028 -80 | -3% | -$7.66K |
|
387
Wendy's
WEN
$2.02B
| $290K | 0.02% | 14,813 +694 | +5% | +$13.6K |
|
388
M&T Bank
MTB
$31.5B
| $288K | 0.02% | 1,693 -45 | -3% | -$7.66K |
|
389
Genuine Parts
GPC
$19.4B
| $287K | 0.02% | 2,767 -40 | -1% | -$4.15K |
|
390
Donaldson
DCI
$9.28B
| $283K | 0.02% | 5,558 | – | – |
|
391
Vanguard Mid-Cap ETF
VO
$87.5B
| $283K | 0.02% | 1,690 -435 | -20% | -$72.8K |
|
|
CIM
392
Chimera Investment
CIM
$1.15B
| $282K | 0.02% | +14,923 | New | +$282K |
|
393
Vanguard Small-Cap ETF
VB
$66.4B
| $279K | 0.02% | 1,782 -185 | -9% | -$29K |
|
394
Enpro
NPO
$4.57B
| $278K | 0.02% | 4,359 +1,067 | +32% | +$68K |
|
395
GSK
GSK
$79.9B
| $273K | 0.02% | 6,813 -1,204 | -15% | -$48.2K |
|
396
Hancock Whitney
HWC
$5.33B
| $270K | 0.02% | 6,734 +956 | +17% | +$38.3K |
|
397
International Flavors & Fragrances
IFF
$17.3B
| $268K | 0.02% | 1,847 | – | – |
|
398
Valvoline
VVV
$4.93B
| $266K | 0.02% | 13,636 | – | – |
|
399
Celanese
CE
$5.22B
| $265K | 0.02% | 2,462 | – | – |
|
|
CHX
400
DELISTED
ChampionX
CHX
| $264K | 0.02% | 7,857 -4,883 | -38% | -$164K |
|